{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:21:17Z","timestamp":1791516077264,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370696"],"award-info":[{"award-number":["82370696"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06554-8","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:53:08Z","timestamp":1751629988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Uncovering key markers and therapeutic targets for renal fibrosis in diabetic kidney disease through bulk and single-cell RNA sequencing"],"prefix":"10.1186","volume":"23","author":[{"given":"Lijuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayinigaer","family":"Yusufu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"issue":"5","key":"6554_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrneph.2018.9","volume":"14","author":"JM Forbes","year":"2018","unstructured":"Forbes JM, Thorburn DR. Mitochondrial dysfunction in diabetic kidney disease. Nat Rev Nephrol. 2018;14(5):291\u2013312. https:\/\/doi.org\/10.1038\/nrneph.2018.9.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"6554_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41581-024-00827-z","volume":"20","author":"DH van Raalte","year":"2024","unstructured":"van Raalte DH, Bjornstad P, Cherney DZI, de Boer IH, Fioretto P, Gordin D, et al. Combination therapy for kidney disease in people with diabetes mellitus. Nat Rev Nephrol. 2024;20(7):433\u201346. https:\/\/doi.org\/10.1038\/s41581-024-00827-z.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"6554_CR3","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.2337\/dci23-0030","volume":"46","author":"SC Naaman","year":"2023","unstructured":"Naaman SC, Bakris GL. Diabetic nephropathy: update on pillars of therapy slowing progression. Diabet Care. 2023;46(9):1574\u201386. https:\/\/doi.org\/10.2337\/dci23-0030.","journal-title":"Diabet Care"},{"issue":"8","key":"6554_CR4","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2215\/cjn.11111016","volume":"12","author":"SM Doshi","year":"2017","unstructured":"Doshi SM, Friedman AN. Diagnosis and management of type 2 diabetic kidney disease. Clin J Am Soc Nephrol CJASN. 2017;12(8):1366\u201373. https:\/\/doi.org\/10.2215\/cjn.11111016.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"1","key":"6554_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1681\/asn.2010111210","volume":"23","author":"M Lin","year":"2012","unstructured":"Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, Au WS, et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol. 2012;23(1):86\u2013102. https:\/\/doi.org\/10.1681\/asn.2010111210.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"6554_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12933-017-0547-1","volume":"16","author":"H Zou","year":"2017","unstructured":"Zou H, Zhou B, Xu G. SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease. Cardiovasc Diabetol. 2017;16(1):65. https:\/\/doi.org\/10.1186\/s12933-017-0547-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"6554_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","volume":"17","author":"RA DeFronzo","year":"2021","unstructured":"DeFronzo RA, Reeves WB, Awad AS. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat Rev Nephrol. 2021;17(5):319\u201334. https:\/\/doi.org\/10.1038\/s41581-021-00393-8.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"6554_CR8","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","volume":"71","author":"K Umanath","year":"2018","unstructured":"Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis. 2018;71(6):884\u201395. https:\/\/doi.org\/10.1053\/j.ajkd.2017.10.026.","journal-title":"Am J Kidney Dis"},{"key":"6554_CR9","doi-asserted-by":"publisher","first-page":"155195","DOI":"10.1016\/j.metabol.2022.155195","volume":"131","author":"L Yao","year":"2022","unstructured":"Yao L, Liang X, Qiao Y, Chen B, Wang P, Liu Z. Mitochondrial dysfunction in diabetic tubulopathy. Metab Clin Exp. 2022;131:155195. https:\/\/doi.org\/10.1016\/j.metabol.2022.155195.","journal-title":"Metab Clin Exp"},{"issue":"1","key":"6554_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdi.12255","volume":"6","author":"Y Maezawa","year":"2015","unstructured":"Maezawa Y, Takemoto M, Yokote K. Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes. J Diabetes Investig. 2015;6(1):3\u201315. https:\/\/doi.org\/10.1111\/jdi.12255.","journal-title":"J Diabetes Investig"},{"issue":"2","key":"6554_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00125-011-2364-5","volume":"55","author":"SM Ka","year":"2012","unstructured":"Ka SM, Yeh YC, Huang XR, Chao TK, Hung YJ, Yu CP, et al. Kidney-targeting Smad7 gene transfer inhibits renal TGF-\u03b2\/MAD homologue (SMAD) and nuclear factor \u03baB (NF-\u03baB) signalling pathways, and improves diabetic nephropathy in mice. Diabetologia. 2012;55(2):509\u201319. https:\/\/doi.org\/10.1007\/s00125-011-2364-5.","journal-title":"Diabetologia"},{"key":"6554_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ebiom.2019.09.002","volume":"48","author":"F Huang","year":"2019","unstructured":"Huang F, Wang Q, Guo F, Zhao Y, Ji L, An T, et al. FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease. EBioMedicine. 2019;48:491\u2013504. https:\/\/doi.org\/10.1016\/j.ebiom.2019.09.002.","journal-title":"EBioMedicine"},{"issue":"11","key":"6554_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41581-021-00462-y","volume":"17","author":"M Oshima","year":"2021","unstructured":"Oshima M, Shimizu M, Yamanouchi M, Toyama T, Hara A, Furuichi K, et al. Trajectories of kidney function in diabetes: a clinicopathological update. Nat Rev Nephrol. 2021;17(11):740\u201350. https:\/\/doi.org\/10.1038\/s41581-021-00462-y.","journal-title":"Nat Rev Nephrol"},{"key":"6554_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baac095","author":"C Wang","year":"2022","unstructured":"Wang C, Chen T, Mu Y, Liang X, Xiong K, Ai L, et al. FDRdb: a manually curated database of fibrotic disease-associated RNAome and high-throughput datasets. Database. 2022. https:\/\/doi.org\/10.1093\/database\/baac095.","journal-title":"Database"},{"key":"6554_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinform"},{"key":"6554_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinform"},{"issue":"1","key":"6554_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"key":"6554_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fnagi.2017.00329","volume":"9","author":"A Sarica","year":"2017","unstructured":"Sarica A, Cerasa A, Quattrone A. Random forest algorithm for the classification of neuroimaging data in Alzheimer\u2019s disease: a systematic review. Front Aging Neurosci. 2017;9:329. https:\/\/doi.org\/10.3389\/fnagi.2017.00329.","journal-title":"Front Aging Neurosci"},{"issue":"W1","key":"6554_CR19","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, et al. GeneMANIA update 2018. Nucl Acid Res. 2018;46(W1):W60\u20134. https:\/\/doi.org\/10.1093\/nar\/gky311.","journal-title":"Nucl Acid Res"},{"issue":"43","key":"6554_CR20","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6554_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2022.12.088","volume":"195","author":"Q Lu","year":"2023","unstructured":"Lu Q, Yang L, Xiao JJ, Liu Q, Ni L, Hu JW, et al. Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK\/NRF2 pathway. Free Radical Biol Med. 2023;195:89\u2013102. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.12.088.","journal-title":"Free Radical Biol Med"},{"issue":"4","key":"6554_CR22","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1021\/acs.jcim.2c01253","volume":"63","author":"BI Tingle","year":"2023","unstructured":"Tingle BI, Tang KG, Castanon M, Gutierrez JJ, Khurelbaatar M, Dandarchuluun C, et al. ZINC-22\u2014a free multi-billion-scale database of tangible compounds for ligand discovery. J Chem Inf Model. 2023;63(4):1166\u201376. https:\/\/doi.org\/10.1021\/acs.jcim.2c01253.","journal-title":"J Chem Inf Model"},{"issue":"4","key":"6554_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2337\/db16-0796","volume":"66","author":"RE Gilbert","year":"2017","unstructured":"Gilbert RE. Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease. Diabetes. 2017;66(4):791\u2013800. https:\/\/doi.org\/10.2337\/db16-0796.","journal-title":"Diabetes"},{"issue":"5","key":"6554_CR24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2337\/db16-0397","volume":"66","author":"A Takahashi","year":"2017","unstructured":"Takahashi A, Takabatake Y, Kimura T, Maejima I, Namba T, Yamamoto T, et al. Autophagy inhibits the accumulation of advanced glycation end products by promoting lysosomal biogenesis and function in the kidney proximal tubules. Diabetes. 2017;66(5):1359\u201372. https:\/\/doi.org\/10.2337\/db16-0397.","journal-title":"Diabetes"},{"issue":"6","key":"6554_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1681\/asn.2009030242","volume":"21","author":"ML Brezniceanu","year":"2010","unstructured":"Brezniceanu ML, Lau CJ, Godin N, Ch\u00e9nier I, Duclos A, Ethier J, et al. Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy. J Am Soc Nephrol. 2010;21(6):943\u201354. https:\/\/doi.org\/10.1681\/asn.2009030242.","journal-title":"J Am Soc Nephrol"},{"key":"6554_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103062","volume":"70","author":"H Chen","year":"2024","unstructured":"Chen H, Zhang H, Li AM, Liu YT, Liu Y, Zhang W, et al. VDR regulates mitochondrial function as a protective mechanism against renal tubular cell injury in diabetic rats. Redox Biol. 2024;70: 103062. https:\/\/doi.org\/10.1016\/j.redox.2024.103062.","journal-title":"Redox Biol"},{"issue":"5","key":"6554_CR27","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/s41401-022-00997-1","volume":"44","author":"HF Zhang","year":"2023","unstructured":"Zhang HF, Liu HM, Xiang JY, Zhou XC, Wang D, Chen RY, et al. Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXR\u03b1 expression and activation. Acta Pharmacol Sin. 2023;44(5):1051\u201365. https:\/\/doi.org\/10.1038\/s41401-022-00997-1.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"6554_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2184.2012.00842.x","volume":"45","author":"LK Donovan","year":"2012","unstructured":"Donovan LK, Pilkington GJ. CD133: holy of grail of neuro-oncology or promiscuous red-herring? Cell Prolif. 2012;45(6):527\u201337. https:\/\/doi.org\/10.1111\/j.1365-2184.2012.00842.x.","journal-title":"Cell Prolif"},{"issue":"4","key":"6554_CR29","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/hep.27968","volume":"62","author":"C Won","year":"2015","unstructured":"Won C, Kim BH, Yi EH, Choi KJ, Kim EK, Jeong JM, et al. Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma. Hepatology (Baltimore, MD). 2015;62(4):1160\u201373. https:\/\/doi.org\/10.1002\/hep.27968.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"1","key":"6554_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.gastro.2021.09.044","volume":"162","author":"X Liang","year":"2022","unstructured":"Liang X, Duronio GN, Yang Y, Bala P, Hebbar P, Spisak S, et al. An enhancer-driven stem cell-like program mediated by SOX9 blocks intestinal differentiation in colorectal cancer. Gastroenterology. 2022;162(1):209\u201322. https:\/\/doi.org\/10.1053\/j.gastro.2021.09.044.","journal-title":"Gastroenterology"},{"key":"6554_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-4598-13-15","volume":"13","author":"Q Ding","year":"2014","unstructured":"Ding Q, Miyazaki Y, Tsukasa K, Matsubara S, Yoshimitsu M, Takao S. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis. Mol Cancer. 2014;13:15. https:\/\/doi.org\/10.1186\/1476-4598-13-15.","journal-title":"Mol Cancer"},{"issue":"5","key":"6554_CR32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/neuonc\/nor022","volume":"13","author":"A Raso","year":"2011","unstructured":"Raso A, Mascelli S, Biassoni R, Nozza P, Kool M, Pistorio A, et al. High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma. Neuro Oncol. 2011;13(5):500\u20138. https:\/\/doi.org\/10.1093\/neuonc\/nor022.","journal-title":"Neuro Oncol"},{"issue":"1","key":"6554_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41375-020-0808-y","volume":"35","author":"L Godfrey","year":"2021","unstructured":"Godfrey L, Crump NT, O\u2019Byrne S, Lau IJ, Rice S, Harman JR, et al. H3K79me2\/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1\/CD133 in MLL-AF4 leukemia cells. Leukemia. 2021;35(1):90\u2013106. https:\/\/doi.org\/10.1038\/s41375-020-0808-y.","journal-title":"Leukemia"},{"issue":"10","key":"6554_CR34","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1164\/rccm.200809-1390OC","volume":"179","author":"D Germano","year":"2009","unstructured":"Germano D, Blyszczuk P, Valaperti A, Kania G, Dirnhofer S, Landmesser U, et al. Prominin-1\/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179(10):939\u201349. https:\/\/doi.org\/10.1164\/rccm.200809-1390OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"6554_CR35","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s12276-022-00831-y","volume":"54","author":"H Lee","year":"2022","unstructured":"Lee H, Yu DM, Bahn MS, Kwon YJ, Um MJ, Yoon SY, et al. Hepatocyte-specific prominin-1 protects against liver injury-induced fibrosis by stabilizing SMAD7. Exp Mol Med. 2022;54(8):1277\u201389. https:\/\/doi.org\/10.1038\/s12276-022-00831-y.","journal-title":"Exp Mol Med"},{"issue":"6","key":"6554_CR36","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1002\/hep.30550","volume":"69","author":"JA Zagory","year":"2019","unstructured":"Zagory JA, Fenlon M, Dietz W, Zhao M, Nguyen MV, Trinh P, et al. Prominin-1 promotes biliary fibrosis associated with biliary atresia. Hepatology (Baltimore, MD). 2019;69(6):2586\u201397. https:\/\/doi.org\/10.1002\/hep.30550.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"6","key":"6554_CR37","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2023.02.017","volume":"186","author":"DD Liu","year":"2023","unstructured":"Liu DD, He JQ, Sinha R, Eastman AE, Toland AM, Morri M, et al. Purification and characterization of human neural stem and progenitor cells. Cell. 2023;186(6):1179-94.e15. https:\/\/doi.org\/10.1016\/j.cell.2023.02.017.","journal-title":"Cell"},{"issue":"1","key":"6554_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-022-02283-8","volume":"41","author":"S Mancarella","year":"2022","unstructured":"Mancarella S, Serino G, Gigante I, Cigliano A, Ribback S, Sanese P, et al. CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype. J Exp Clin Cancer res CR. 2022;41(1):65. https:\/\/doi.org\/10.1186\/s13046-022-02283-8.","journal-title":"J Exp Clin Cancer res CR"},{"issue":"6","key":"6554_CR39","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1073\/pnas.1222047110","volume":"110","author":"A Kupz","year":"2013","unstructured":"Kupz A, Scott TA, Belz GT, Andrews DM, Greyer M, Lew AM, et al. Contribution of Thy1+ NK cells to protective IFN-\u03b3 production during Salmonella typhimurium infections. Proc Natl Acad Sci USA. 2013;110(6):2252\u20137. https:\/\/doi.org\/10.1073\/pnas.1222047110.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"6554_CR40","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41584-022-00858-5","volume":"18","author":"R Phillips","year":"2022","unstructured":"Phillips R. Thy-1 promotes skin fibrosis in SSc. Nat Rev Rheumatol. 2022;18(11):613. https:\/\/doi.org\/10.1038\/s41584-022-00858-5.","journal-title":"Nat Rev Rheumatol"},{"key":"6554_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.928510","volume":"10","author":"P Hu","year":"2022","unstructured":"Hu P, Leyton L, Hagood JS, Barker TH. Thy-1-integrin interactions in cis and trans mediate distinctive signaling. Front Cell Dev Biol. 2022;10: 928510. https:\/\/doi.org\/10.3389\/fcell.2022.928510.","journal-title":"Front Cell Dev Biol"},{"key":"6554_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131152","author":"C Tan","year":"2019","unstructured":"Tan C, Jiang M, Wong SS, Espinoza CR, Kim C, Li X, et al. Soluble Thy-1 reverses lung fibrosis via its integrin-binding motif. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.131152.","journal-title":"JCI Insight"},{"key":"6554_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119824","volume":"236","author":"Y Li","year":"2020","unstructured":"Li Y, Song D, Mao L, Abraham DM, Bursac N. Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure. Biomaterials. 2020;236: 119824. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119824.","journal-title":"Biomaterials"},{"key":"6554_CR44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101270118","author":"T Nishio","year":"2021","unstructured":"Nishio T, Koyama Y, Liu X, Rosenthal SB, Yamamoto G, Fuji H, et al. Immunotherapy-based targeting of MSLN(+) activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis. Proceed Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2101270118.","journal-title":"Proceed Natl Acad Sci U S A"},{"key":"6554_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031896","author":"A Saalbach","year":"2023","unstructured":"Saalbach A, Anderegg U, Wendt R, Beige J, Bachmann A, Kl\u00f6ting N, et al. Antifibrotic soluble Thy-1 correlates with renal dysfunction in chronic kidney disease. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24031896.","journal-title":"Int J Mol Sci"},{"key":"6554_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149426","author":"RG Marangoni","year":"2022","unstructured":"Marangoni RG, Datta P, Paine A, Duemmel S, Nuzzo M, Sherwood L, et al. Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in scleroderma. JCI Insight. 2022. https:\/\/doi.org\/10.1172\/jci.insight.149426.","journal-title":"JCI Insight"},{"issue":"4","key":"6554_CR47","doi-asserted-by":"publisher","first-page":"qzae056","DOI":"10.1093\/gpbjnl\/qzae056","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y et al. Characterization of cancer stem cells in laryngeal squamous cell carcinoma by single-cell RNA\nsequencing. Genomics Proteomics Bioinform. 2024;22(4):qzae056. https:\/\/doi.org\/10.1093\/gpbjnl\/qzae056.","journal-title":"Genomics Proteomics Bioinform."},{"issue":"8","key":"6554_CR48","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/labinvest.2011.80","volume":"91","author":"G Ram\u00edrez","year":"2011","unstructured":"Ram\u00edrez G et al. Absence of Thy-1 results in TGF-\u03b2 induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts. Lab Invest J Tech Methods Pathol. 2011;91(8):1206-18. https:\/\/doi.org\/10.1038\/labinvest.2011.80.","journal-title":"Lab Invest J Tech Methods Pathol."},{"issue":"6","key":"6554_CR49","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/j.1523-1755.2004.66012.x","volume":"66","author":"H Peters","year":"2004","unstructured":"Peters, H et al. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis. Kidney Int. 2004;66(6):2224-36. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.66012.x.","journal-title":"Kidney Int"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06554-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06554-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06554-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:53:08Z","timestamp":1751629988000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06554-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6554"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06554-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments conducted in this research were reviewed and authorized by the Ethics Committee of Zhongnan Hospital at Wuhan University (Ethical Clearance: ZN2024016).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"742"}}